Meeting
2024 ASCO Genitourinary Cancers Symposium
Impact of intraoperative tranexamic acid use on overall survival and cancer specific survival in patients undergoing radical cystectomy.
Authors
Mohamed E. Ahmed
Mayo Clinic Rochester, Rochester, MN
Mohamed E. Ahmed , Jack R. Andrews , Ahmed M. Mahmoud , Prabin Thapa , Abhinav Khanna , Paras Shah , Vidit Sharma , R. Houston Thompson , Matthew K. Tollefson , Igor Frank , R. Jeffrey Karnes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 642)
DOI
10.1200/JCO.2024.42.4_suppl.642
Abstract #
642
Poster Bd #
J6
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Comparing radical cystectomy with trimodal therapy for patients diagnosed with bladder cancer: Critical assessment of statistical methodology and interpretation of observational data.
First Author: Mohamed Danny Ray-Zack
Poster
2024 ASCO Genitourinary Cancers Symposium
Pathologic and survival outcomes following radical cystectomy for “progressive” and “de novo” muscle-invasive bladder cancer: A meta-analysis stratified by neoadjuvant chemotherapy status.
First Author: Leilei Xia
Poster
2022 ASCO Genitourinary Cancers Symposium
The prognostic impact of preoperative health-related quality life on bladder-cancer-specific survival in patients treated with radical cystectomy.
First Author: Thilo Westhofen
Poster
2022 ASCO Genitourinary Cancers Symposium
Survival outcomes with radical cystectomy (RC) in localized clinically node-positive bladder cancer (CNBC).
First Author: Stuthi Perimbeti